3Navab K D,Elboudwarej O,Gharif M,et al.Chronic inflammatorydisorders and accelerated atherosclerosis:chronic kidney disease[J].Curr Pharm Des,2011,17(1):17-20.
4Zoccali C,Tripepi G,Mallamaci F.Dissecting inflammation inESRD:do cytokines and C-reactive protein have a complementaryprognostic value for mortality in dialysis patients?[J].J Am SocNephrol,2006,17(12 Suppl 3):S169-S173.
5Krane V,Wanner C.Statins,inflammation and kidney disease[J].Nat Rev Nephrol,2011,7(7):385-397.
6Barreto D V,Barreto F C,Liabeuf S,et al.Plasma interleukin-6 isindependently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease[J].Kidney Int,2010,77(6):550-556.
7K/DOQI clinical practice guidelines for cardiovascular disease in dial-ysis patients[J].Am J Kidney Dis,2005,45(4 Suppl 3):S1-S153.
8Menon V,Wang X,Greene T,et al.Relationship between C-reac-tive protein,albumin,and cardiovascular disease in patients withchronic kidney disease[J].Am J Kidney Dis,2003,42(1):44-52.
9Kruger B,Walberer A,Debler J,et al.Is inflammation prior to renaltransplantation predictive for cardiovascular and renal outcomes?[J].Atherosclerosis,2010,210(2):637-642.
10Abedini S,Holme I,Marz W,et al.Inflammation in renal transplan-tation[J].Clin J Am Soc Nephrol,2009,4(7):1246-1254.
